Drugs / zolmitriptane
last change Jan 2024 re-read 2 minutes ago

zolmitriptane

Developed for
migraine disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06089356 Comparator Jan 2023 → Jan 2024 migraine disorder Tanta University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as zolmitriptane ClinicalTrials.gov intervention name — accepted as the source's own label NCT06089356